Susan Margaret Hall

Title: The Innovations of Susan Margaret Hall

Introduction

Susan Margaret Hall is a notable inventor based in Adlington, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target tumor-associated antigens. Her work has implications for cancer research and treatment, showcasing her dedication to advancing medical science.

Latest Patents

Susan holds a patent for "Antibodies recognizing tumor associated antigen CA 55.1." This patent describes antibodies that recognize a tumor-related antigen designated CA55.1, including hybridoma 55.1, which has been deposited as ECACC deposit no. 93081901. The complementarity determining regions of these antibodies have specific sequences that enhance their effectiveness in targeting cancer cells.

Career Highlights

Throughout her career, Susan has been associated with Zeneca Limited, a company known for its innovative approaches in pharmaceuticals and biotechnology. Her work at Zeneca has allowed her to contribute to groundbreaking research and development in the field.

Collaborations

Susan has collaborated with esteemed colleagues, including Michael Samuel Rose and Christopher Boot. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

Susan Margaret Hall's contributions to the field of biotechnology, particularly through her patent on tumor-associated antibodies, highlight her role as an influential inventor. Her work continues to inspire advancements in cancer treatment and research.